首页> 外文期刊>Journal of the American Academy of Child and Adolescent Psychiatry >2.23 Efficacy and Safety of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) in Children With ADHD: Results From a Pivotal Phase 3 Classroom Trial

【24h】

2.23 Efficacy and Safety of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) in Children With ADHD: Results From a Pivotal Phase 3 Classroom Trial

机译：2.23延迟释放和延长释放甲基苯胺（DR / ER-MPH）的疗效和安全性与ADHD的儿童：关键阶段3课堂试验结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the American Academy of Child and Adolescent Psychiatry》 |2018年第10期|共1页
作者
Ann Catherine Childress; Andrew J. Cutler; Andrea Marraffino; Norberto J. DeSousa; Bev Incledon; F. Randy Sallee;
展开▼
作者单位

Center for Psychiatry and Behavioral Medicine Inc;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. 2.23 Efficacy and Safety of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) in Children With ADHD: Results From a Pivotal Phase 3 Classroom Trial [J] . Ann Catherine Childress, Andrew J. Cutler, Andrea Marraffino, Journal of the American Academy of Child and Adolescent Psychiatry . 2018,第10期

机译：2.23延迟释放和延长释放甲基苯胺（DR / ER-MPH）的疗效和安全性与ADHD的儿童：关键阶段3课堂试验结果
2. 2.31 Effect of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) on All-Day and Early Morning ADHD-Related Symptoms: Analysis of ADHD-Rating Scale-IV and ADHD-AM-Rating Scale Items From a Phase 3 Trial [J] . Steven R. Pliszka, Valerie K. Arnold, Andrea Marraffino, Journal of the American Academy of Child and Adolescent Psychiatry . 2018,第10期

机译：2.31延迟释放和延长释放甲基苯胺（DR / ER-MPH）对杂志和清晨的疗效相关的症状：分析ADHD评级SCALE-IV和ADHD-AM-Rating Scale项目从阶段3 审判
3. 2.31 Effect of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) on All-Day and Early Morning ADHD-Related Symptoms: Analysis of ADHD-Rating Scale-IV and ADHD-AM-Rating Scale Items From a Phase 3 Trial [J] . Steven R. Pliszka, Valerie K. Arnold, Andrea Marraffino, Journal of the American Academy of Child and Adolescent Psychiatry . 2018,第10期

机译：2.31延迟释放和延长释放甲基苯胺（DR / ER-MPH）对杂志和清晨的疗效相关的症状：分析ADHD评级SCALE-IV和ADHD-AM-Rating Scale项目从阶段3 审判
4. BlurtLine: A Design Exploration to Support Children with ADHD in Classrooms [C] . Dorothe Smit, Saskia Bakker IFIP TC 13 International Conference on Human-Computer Interaction . 2015

机译：BlurtLine：在教室中为患有多动症的儿童提供支持的设计探索
5. An examination of an assessment tool to monitor the functioning of children diagnosed with ADHD receiving placebo and three intensities of methylphenidate across multiple settings. [D] . Naylor, Justin A. 2010

机译：评估工具的检查，以监测被诊断患有多动症的儿童接受安慰剂和三种强度的哌醋甲酯在多种情况下的功能。
6. Efficacy and Safety of HLD200 Delayed-Release and Extended-Release Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder [O] . Steven R. Pliszka, Timothy E. Wilens, Samantha Bostrom, -1

机译：HLD200延迟释放和长时间释放哌醋甲酯对注意力缺乏/多动症儿童的疗效和安全性
7. Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study [O] . Ann C. Childress, Matthew N. Brams, Andrew J. Cutler, 2020

机译：6-12岁以下儿童的多层延长甲基苯胺（PRC-063）的疗效和安全性，注意力缺陷/多动障碍：一个实验室课堂研究
8. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号